ProKidney Corp.

NASDAQ: PROK · Real-Time Price · USD
2.38
-0.04 (-1.65%)
At close: Aug 15, 2025, 3:46 PM

ProKidney Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
527K 306K 76K 4.49M 4.49M 4.49M 4.49M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
1.2M 2.16M 3M 4.03M 3.69M 3.43M 3.28M 3.3M 2.44M 1.73M 1.05M n/a n/a n/a n/a n/a n/a n/a
Gross Profit
-893K -1.86M -2.92M 468K 806K 1.06M 1.22M -3.3M -2.44M -1.73M -1.05M n/a n/a n/a n/a n/a n/a n/a
Operating Income
-141.93M -184.99M -183.68M -156.31M -153.96M -150.72M -151.52M -157.55M -146.5M -127.42M -153.01M -136.48M -117.99M -109.97M -55.11M -49.21M -32.13M -19.41M
Interest Income
17.99M 18.94M 19.75M 20.24M 20.2M 21.63M 22.08M 21.2M 17.25M 11.28M 5.98M 1.58M 1K 3K 3K 2K 2K n/a
Pretax Income
-163.65M -166.06M -163.93M -136.09M -133.77M -129.1M -129.45M -136.35M -129.29M -116.34M -147.24M -135.11M -118.17M -109.98M -55.11M -49.21M -32.13M -19.41M
Net Income
-76.33M -68.43M -61.19M -45.61M -38.68M -35.3M -35.47M -54.34M -55.28M -68.3M -126.12M -115.22M -120.43M -111.02M -55.15M -49.09M -31.95M -19.22M
Selling & General & Admin
57.99M 57.6M 56.08M 45.9M 42.6M 42.4M 44.81M 52.48M 52.5M 48.22M 70.94M 64.62M 52.52M 45.08M 8.86M 7.25M 4.91M 3.16M
Research & Development
124.18M 127.7M 127.67M 110.42M 111.36M 108.32M 106.71M 105.07M 94M 79.2M 82.07M 71.86M 65.47M 64.89M 46.26M 41.96M 27.21M 16.25M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
182.17M 185.29M 183.75M 156.31M 153.96M 150.72M 151.52M 157.55M 146.5M 127.42M 153.01M 136.48M 117.99M 109.97M 55.11M 49.21M 32.13M 19.41M
Interest Expense
3K 7K 9K 10K 10K 11K 12K 11K 38K 204K 215K 213K 185K 15K 1K 1K n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 314K 314K 314K
Cost & Expenses
142.24M 185.29M 183.75M 156.31M 153.96M 150.72M 151.52M 157.55M 146.5M 127.42M 153.01M 136.48M 117.99M 109.97M 55.11M 49.21M 32.13M 19.41M
Income Tax Expense
799K -105K -598K 491K 3.75M 4.77M 6M 1.94M 955K 1.21M 896K 2.12M 2.25M 1.04M 38K 270K 210K 200K
Shares Outstanding (Basic)
130.73M 128.98M 128.05M 126.17M 75.91M 60.95M 59.88M 61.59M 64.56M 61.54M 61.54M 61.54M 61.54M 31.89M 31.89M 31.89M 31.96M 32.27M
Shares Outstanding (Diluted)
130.73M 128.98M 128.05M 126.17M 75.91M 60.95M 59.88M 61.59M 64.56M 61.54M 61.54M 61.54M 61.54M 31.89M 31.89M 31.89M 31.96M 32.27M
EPS (Basic)
-0.57 -0.6 -0.63 -0.56 -0.6 -0.58 -1.02 -1.32 -1.33 -1.55 -1.07 -0.74 -0.56 -0.27 -0.2 -0.2 -0.2 -0.13
EPS (Diluted)
-0.57 -0.6 -0.63 -0.56 -0.6 -0.58 -1.02 -1.32 -1.33 -1.55 -1.07 -0.74 -0.56 -0.27 -0.2 -0.2 -0.2 -0.13
EBITDA
-122.87M -160.12M -158.49M -131.07M -129.24M -124.97M -125.59M -132.59M -125.82M -112.83M -143.83M -132.17M -115.42M -107.64M -53.13M -47.56M -31M -18.8M
EBIT
-127.53M -166.05M -163.92M -136.07M -133.76M -129.09M -129.44M -136.34M -129.26M -116.14M -147.02M -134.9M -117.99M -109.97M -55.11M -49.21M -32.13M -19.41M
Depreciation & Amortization
4.66M 5.93M 5.43M 5M 4.52M 4.12M 3.85M 3.76M 3.54M 3.42M 3.29M 2.83M 2.57M 2.33M 1.98M 1.65M 1.13M 611K